peptide elongation factor 2 has been researched along with Leukemia, Myeloid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, X; Zuckerman, KS | 1 |
1 review(s) available for peptide elongation factor 2 and Leukemia, Myeloid
| Article | Year |
|---|---|
Cell cycle and transcriptional control of human myeloid leukemic cells by transforming growth factor beta.
Topics: CDC2-CDC28 Kinases; Cell Cycle; Cell Cycle Proteins; Cell Division; Cyclin E; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p27; Cyclin-Dependent Kinases; Gene Expression Regulation, Leukemic; Growth Inhibitors; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid; Macromolecular Substances; Microtubule-Associated Proteins; Neoplasm Proteins; Neoplastic Stem Cells; Nuclear Proteins; Peptide Elongation Factor 2; Phosphoproteins; Phosphorylation; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Proteins; Retinoblastoma Protein; Retinoblastoma-Like Protein p107; Retinoblastoma-Like Protein p130; Transcription Factors; Transcription, Genetic; Transforming Growth Factor beta; Transforming Growth Factor beta1; Tumor Cells, Cultured; Tumor Suppressor Proteins | 2000 |